Akshat Jain/LinkedIn
Jul 13, 2026, 15:23
Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared a post on LinkedIn:
”’International Society on Thrombosis and Haemostasis (ISTH) 2026 meeting in Paris provided a great platform to interact with colleagues around the world and present our real world case scenario in Bleeding Disorder’s and other research work
Takeaways:
- Gene therapy is alive and well and powerful advances in the field coming in the next 5 years – Wolfgang Miesbach
- Novel drug delivery is going to change how we offer therapies . Inno8 was very exciting – Novo Nordisk
- Von Willebrand Disease : underserved population such as young children and women with bleeding have amazing new options that are looking beyond ‘Just Bleeding’. Sarcopenia, anemia and fatigue with therapies new target to study Octapharma
- Safety of Rebalancing agents assessed and more real world data very promising – Pfizer
- I.T.P. : subcutaneous therapy once a week targeting pro coagulation like protein C and S would add another layer of protection in addition to Rizlabrutinib from Sanofi
Women with blood disorders is finding more representation in novel therapeutics and personalized therapies Angela Weyand, Flora Peyvandi.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026
-
Jul 13, 2026, 16:06Dino Mehic: Honored to Receive the ISTH Early Career Top Reviewer Awards
-
Jul 13, 2026, 16:01Advancing DIC Diagnosis in Cirrhosis Through Disease-Specific Risk Stratification – JTH
-
Jul 13, 2026, 15:52Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026
-
Jul 13, 2026, 15:42Marc Carrier: Important New Data From the API-CAT Trial on Recurrent VTE During Extended Apixaban Therapy